uni-leipzig-open-access/json/a-1516-2731

{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T07:29:57Z","timestamp":1701329397099},"reference-count":35,"publisher":"Georg Thieme Verlag KG","issue":"10","license":[{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch Med Wochenschr"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1055\/a-1516-2731","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T22:41:41Z","timestamp":1682030501000},"page":"627-635","source":"Crossref","is-referenced-by-count":2,"title":["HDL \u2013 Quo vadis"],"prefix":"10.1055","volume":"148","author":[{"given":"Arnold","family":"von Eckardstein","sequence":"additional","affiliation":[]},{"given":"Winfried","family":"M\u00e4rz","sequence":"additional","affiliation":[]},{"given":"Ulrich","family":"Laufs","sequence":"additional","affiliation":[]}],"member":"194","published-online":{"date-parts":[[2023,4,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"ehac605","DOI":"10.1093\/eurheartj\/ehac605","article-title":"High-density lipoprotein revisited: biological functions and clinical relevance","author":"A von Eckardstein","year":"2022","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1161\/ATVBAHA.120.314050","article-title":"Novel Insights From Human Studies on the Role of High-Density Lipoprotein in Mortality and Noncardiovascular Disease","volume":"41","author":"CM Madsen","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1161\/CIRCULATIONAHA.120.044221","article-title":"HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research","volume":"143","author":"A Rohatgi","year":"2021","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/978-3-319-09665-0_9","article-title":"Mouse models of disturbed HDL metabolism","volume":"224","author":"M Hoekstra","year":"2015","journal-title":"Handb Exp Pharmacol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e1737","DOI":"10.1002\/wnan.1737","article-title":"Artificial high-density lipoprotein- mimicking nanotherapeutics for the treatment of cardiovascular diseases","volume":"13","author":"H He","year":"2021","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1126\/science.aad3517","article-title":"Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease","volume":"351","author":"P Zanoni","year":"2016","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"dgz265","DOI":"10.1210\/clinem\/dgz265","article-title":"Low High-Density Lipoprotein Cholesterol to Monitor Long-Term Average Increased Triglycerides","volume":"105","author":"A Langsted","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"E Di Angelantonio","year":"2009","journal-title":"JAMA"},{"key":"ref9","volume-title":"High Density Lipoproteins: Is There a Comeback as a Therapeutic Target?","author":"A von Eckardstein","year":"2022"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"159063","DOI":"10.1016\/j.bbalip.2021.159063","article-title":"HDL cholesterol concentrations and risk of atherosclerotic cardiovascular disease \u2013 Insights from randomized clinical trials and human genetics","volume":"1867","author":"EW Kjeldsen","year":"2022","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1056\/NEJMoa2210645","article-title":"Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk","volume":"387","author":"A Das Pradhan","year":"2022","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/MOL.0000000000000854","article-title":"Can we revive CETP-inhibitors for the prevention of cardiovascular disease?","volume":"33","author":"SJ Nicholls","year":"2022","journal-title":"Curr Opin Lipidol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ahj.2020.10.052","article-title":"Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo- controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction","volume":"231","author":"CM Gibson","year":"2021","journal-title":"Am Heart J"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1038\/s41591-022-01936-7","article-title":"Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial","volume":"28","author":"SJ Nicholls","year":"2022","journal-title":"Nat Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"g4379","DOI":"10.1136\/bmj.g4379","article-title":"Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients","volume":"349","author":"D Keene","year":"2014","journal-title":"BMJ"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1001\/jama.2017.11467","article-title":"Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk","volume":"318","author":"BA Ference","year":"2017","journal-title":"JAMA"},{"key":"ref17","doi-asserted-by":"publisher","article-title":"The benefits of measuring the size and number of lipoprotein particles for cardiovascular risk prediction: A systematic review and meta-analysis","author":"JA Quesada","year":"2022","DOI":"10.1016\/j.arteri.2022.11.001"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2020.04.015","article-title":"High density lipoprotein functionality and cardiovascular events and mortality: A systematic review and meta-analysis","volume":"302","author":"MT Soria-Florido","year":"2020","journal-title":"Atherosclerosis"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1161\/CIRCULATIONAHA.117.031276","article-title":"High-Density Lipoprotein Subspecies Defined by Presence of Apolipoprotein C-III and Incident Coronary Heart Disease in Four Cohorts","volume":"137","author":"MK Jensen","year":"2018","journal-title":"Circulation"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"100217","DOI":"10.1016\/j.jlr.2022.100217","article-title":"HDL, heart disease, and the lung","volume":"63","author":"K Frey","year":"2022","journal-title":"J Lipid Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1093\/eurheartj\/ehv352","article-title":"Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk","volume":"36","author":"S Zewinger","year":"2015","journal-title":"Eur Heart J"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1093\/eurheartj\/ehx118","article-title":"Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease","volume":"38","author":"S Zewinger","year":"2017","journal-title":"Eur Heart J"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/978-3-319-09665-0_12","article-title":"HDLs, diabetes, and metabolic syndrome","volume":"224","author":"P Vollenweider","year":"2015","journal-title":"Handb Exp Pharmacol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e013531","DOI":"10.1161\/JAHA.119.013531","article-title":"Role of High-Density Lipoproteins in Cholesterol Homeostasis and Glycemic Control","volume":"9","author":"B Manandhar","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1093\/ehjcvp\/pvac025","article-title":"The effect of CETP inhibitors on new- onset diabetes: a systematic review and meta-analysis","volume":"8","author":"K Dangas","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"764","DOI":"10.3390\/cells10040764","article-title":"High-Density Lipoproteins and the Kidney","volume":"10","author":"A Strazzella","year":"2021","journal-title":"Cells"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1161\/CIRCULATIONAHA.120.048568","article-title":"Inhibition of Cholesteryl Ester Transfer Protein Preserves High-Density Lipoprotein Cholesterol and Improves Survival in Sepsis","volume":"143","author":"M Trinder","year":"2021","journal-title":"Circulation"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3390\/biom10040598","article-title":"High-Density Lipoproteins Are Bug Scavengers","volume":"10","author":"O Meilhac","year":"2020","journal-title":"Biomolecules"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev-physiol-021119-034345","article-title":"APOL1 and Kidney Disease: From Genetics to Biology","volume":"82","author":"DJ Friedman","year":"2020","journal-title":"Annu Rev Physiol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1194\/jlr.M083311","article-title":"Scavenger receptor BI promotes cytoplasmic accumulation of lipoproteins in clear-cell renal cell carcinoma","volume":"59","author":"S Velagapudi","year":"2018","journal-title":"J Lipid Res"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3389\/fendo.2018.00715","article-title":"HDL in Endocrine Carcinomas: Biomarker, Drug Carrier, and Potential Therapeutic","volume":"9","author":"EE Morin","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1007\/s12035-020-02211-x","article-title":"The Interplay of ABC Transporters in A\u03b2 Translocation and Cholesterol Metabolism: Implicating Their Roles in Alzheimer's Disease","volume":"58","author":"T Behl","year":"2021","journal-title":"Mol Neurobiol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e45100","DOI":"10.7554\/eLife.45100","article-title":"Impaired ABCA1\/ABCG1-mediated lipid efflux in the mouse retinal pigment epithelium (RPE) leads to retinal degeneration","volume":"8","author":"F Storti","year":"2019","journal-title":"Elife"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"F Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/MOL.0000000000000833","article-title":"How should low-density lipoprotein cholesterol be calculated in 2022?","volume":"33","author":"J Martins","year":"2022","journal-title":"Curr Opin Lipidol"}],"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1516-2731.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T23:12:21Z","timestamp":1682637141000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1516-2731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,20]]},"references-count":35,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,4,27]]},"published-print":{"date-parts":[[2023,5]]}},"URL":"http:\/\/dx.doi.org\/10.1055\/a-1516-2731","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"value":"0012-0472","type":"print"},{"value":"1439-4413","type":"electronic"}],"subject":["General Medicine"],"published":{"date-parts":[[2023,4,20]]}}}